US4622221004
US4622221004
Ionis Pharmaceuticals, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 7.52B EUR | 13.15B EUR | 12.46B EUR | 12.92B EUR |
Enterprise Value | 7.28B EUR | 14.42B EUR | 14.33B EUR | 14.61B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -40.71x | -- | -- | -- |
Price to Sales | 8.61x | 15.05x | 11.77x | 15.91x |
Price to Book | 17.05x | 29.91x | 25.35x | 26.41x |
EV/Revenue | 8.33x | 16.49x | 13.54x | 17.99x |
EV/EBITDA | -12.57x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.61% | -4.31% | -7.85% | -1.25% |